Text messaging reminders for influenza vaccine in primary care
- Conditions
- Topic: Primary Care Research Network for EnglandSubtopic: Not AssignedDisease: All DiseasesRespiratory
- Registration Number
- ISRCTN48840025
- Lead Sponsor
- ondon School of Hygiene and Tropical Medicine (UK)
- Brief Summary
2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/24793252 2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/26895984
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
1. Practices must use text messaging software to communicate with patients
2. Practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season
3. Practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression
Practices will not send the text message to pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Current primary outcome measures as of 04/11/2015:<br> Proportion of patients who received flu vaccine; Timepoint(s): Up to 4 months<br><br> Previous primary outcome measures:<br> Recruitment rate; Timepoints: 3 months after initial contact<br>
- Secondary Outcome Measures
Name Time Method <br> Current secondary outcome measures as of 04/11/2015:<br> 1. Recruitment rate; Timepoints: 3 months after initial contact<br> 2. Practice delivery of text message; Timepoint(s): One month after study start<br> 3. Proportion of practices reporting yes to difficulties; Timepoint(s): Up to 3 months<br> 4. Were outcome data available?; Timepoint(s): Up to 9 months<br><br> Previous secondary outcome measures:<br> 1. Practice delivery of text message; Timepoint(s): One month after study start<br> 2. Proportion of patients who received flu vaccine; Timepoint(s): Up to 9 months<br> 3. Proportion of practices reporting yes to difficulties; Timepoint(s): Up to 3 months<br> 4. Were outcome data available?; Timepoint(s): Up to 9 months<br>